| 1 | highly | 14,470 |
| 2 | exquisitely | 26 |
| 3 | cell-type | 25 |
| 4 | suxiao | 10 |
| 5 | wrightia | 8 |
| 6 | coaxially | 7 |
| 7 | diaspirin | 6 |
| 8 | non-cox-2 | 6 |
| 9 | hydrolytically | 5 |
| 10 | jnk2/3 | 5 |
| 11 | lowly | 5 |
| 12 | retinotopically | 5 |
| 13 | submaximally | 4 |
| 14 | magnesium-incorporated | 3 |
| 15 | peculiarly | 3 |
| 16 | time-and | 3 |
| 17 | bg-dependent | 2 |
| 18 | colgate® | 2 |
| 19 | conmed | 2 |
| 20 | foran | 2 |
| 21 | h19-differentially | 2 |
| 22 | health-sector | 2 |
| 23 | inconstantly | 2 |
| 24 | locally-produced | 2 |
| 25 | microbe-encapsulated | 2 |
| 26 | non-g6pd | 2 |
| 27 | non-water | 2 |
| 28 | presolidified | 2 |
| 29 | priviledged | 2 |
| 30 | tonally | 2 |
| 31 | tttd-based | 2 |
| 32 | 'wind-cold | 1 |
| 33 | 1-df | 1 |
| 34 | 13-ms | 1 |
| 35 | 158-fold | 1 |
| 36 | 17p-/tp53 | 1 |
| 37 | 1°-32° | 1 |
| 38 | 226-kda | 1 |
| 39 | 23/681 | 1 |
| 40 | 249,040 | 1 |
| 41 | 3'-dh-cama/b | 1 |
| 42 | 3'utr/lectin-like | 1 |
| 43 | 3,5-dihydroxy-4-isopropystilbene | 1 |
| 44 | 30,176 | 1 |
| 45 | 4-substituted-1-tosyl-1,2,3-triazole-based | 1 |
| 46 | 5-ht-based | 1 |
| 47 | adenine-uridine | 1 |
| 48 | agent/regimen | 1 |
| 49 | ain93m | 1 |
| 50 | all-trans-form | 1 |
| 51 | allo-hla | 1 |
| 52 | allograft-demineralized | 1 |
| 53 | anti-body | 1 |
| 54 | anti-glrav-3 | 1 |
| 55 | antiarrhythmically | 1 |
| 56 | berson | 1 |
| 57 | beta-strand | 1 |
| 58 | binary-response | 1 |
| 59 | bpa-dose | 1 |
| 60 | carbon-source | 1 |
| 61 | ccck/18 | 1 |
| 62 | ciebp | 1 |
| 63 | clincially | 1 |
| 64 | conjugally | 1 |
| 65 | coreopsis | 1 |
| 66 | c₃₃₋₄₄ | 1 |
| 67 | donor-acceptor-type | 1 |
| 68 | donor-selected | 1 |
| 69 | double-stimuli | 1 |
| 70 | drug-layered | 1 |
| 71 | dznep-derived | 1 |
| 72 | electrocatalytically | 1 |
| 73 | electropolymeric | 1 |
| 74 | embolising | 1 |
| 75 | erythemally | 1 |
| 76 | evalutionary | 1 |
| 77 | fkb-5 | 1 |
| 78 | glaserian | 1 |
| 79 | goal-conscious | 1 |
| 80 | gtx2,3-aldehyde- | 1 |
| 81 | guanidine-based | 1 |
| 82 | h3.1-containing | 1 |
| 83 | heparin-saturated | 1 |
| 84 | heterogeneously/extremely | 1 |
| 85 | hexadecameric | 1 |
| 86 | high-nociception | 1 |
| 87 | highy | 1 |
| 88 | hippocampal-region | 1 |
| 89 | hiv-suppressing | 1 |
| 90 | hla-f. | 1 |
| 91 | ion- | 1 |
| 92 | isosequential | 1 |
| 93 | literature-guided | 1 |
| 94 | m.d-08 | 1 |
| 95 | magnesium-non | 1 |
| 96 | meca79 | 1 |
| 97 | megalin- | 1 |
| 98 | model.if | 1 |
| 99 | ms/thermally | 1 |
| 100 | multiantibiotic | 1 |
| 101 | nanopatterned | 1 |
| 102 | nm-thick | 1 |
| 103 | non-centrally | 1 |
| 104 | non-dose | 1 |
| 105 | non-gastro | 1 |
| 106 | non-radiating | 1 |
| 107 | non-renin | 1 |
| 108 | non-subunit | 1 |
| 109 | nonfluoxetine | 1 |
| 110 | nongravity | 1 |
| 111 | nonlight | 1 |
| 112 | nonspecifying | 1 |
| 113 | not-yet-annotated | 1 |
| 114 | novel-type | 1 |
| 115 | one-generation | 1 |
| 116 | othermore | 1 |
| 117 | ozone-transfer | 1 |
| 118 | paparella | 1 |
| 119 | partner-bond | 1 |
| 120 | perennially | 1 |
| 121 | perfluorocarbon-exposed | 1 |
| 122 | pet-ether | 1 |
| 123 | physicologist | 1 |
| 124 | phytoestrogen- | 1 |
| 125 | pigmentation-inducing | 1 |
| 126 | plant-bound | 1 |
| 127 | plcc | 1 |
| 128 | polybactrin | 1 |
| 129 | prelyophilized | 1 |
| 130 | promitor™ | 1 |
| 131 | protoglycan-like | 1 |
| 132 | random-priming | 1 |
| 133 | rapid-heat | 1 |
| 134 | relaparatomy | 1 |
| 135 | renouncing | 1 |
| 136 | rheumatoid-like | 1 |
| 137 | self-report-clinician | 1 |
| 138 | ser/pro | 1 |
| 139 | significant/ | 1 |
| 140 | single-place | 1 |
| 141 | sleep-state | 1 |
| 142 | smad2/3-dvl2/3 | 1 |
| 143 | subgame | 1 |
| 144 | subtherapeutically | 1 |
| 145 | succinylnorcocaine | 1 |
| 146 | surpassingly | 1 |
| 147 | target-parameter | 1 |
| 148 | temptative | 1 |
| 149 | tensilely | 1 |
| 150 | thoroughgoing | 1 |
| 151 | tlr4-pathway | 1 |
| 152 | triacylglycerol- | 1 |
| 153 | triaxially | 1 |
| 154 | va/g | 1 |
| 155 | vasomotorically | 1 |
| 156 | water-excluded | 1 |
| 157 | water-vapor | 1 |
| 158 | wider-caliber | 1 |
| 159 | worry/rumination | 1 |
| 160 | x/y/18 | 1 |
| 161 | ~4,800 | 1 |
| 162 | α-1,3-linked | 1 |
| 163 | β-1,6-n-acetylglucosamine | 1 |
| 164 | π-functional | 1 |
| 165 | ≥52-week | 1 |
| 1 | 'wind-cold | 1 |
| 2 | 1-df | 1 |
| 3 | 13-ms | 1 |
| 4 | 158-fold | 1 |
| 5 | 17p-/tp53 | 1 |
| 6 | 1°-32° | 1 |
| 7 | 226-kda | 1 |
| 8 | 23/681 | 1 |
| 9 | 249,040 | 1 |
| 10 | 3'-dh-cama/b | 1 |
| 11 | 3'utr/lectin-like | 1 |
| 12 | 3,5-dihydroxy-4-isopropystilbene | 1 |
| 13 | 30,176 | 1 |
| 14 | 4-substituted-1-tosyl-1,2,3-triazole-based | 1 |
| 15 | 5-ht-based | 1 |
| 16 | adenine-uridine | 1 |
| 17 | agent/regimen | 1 |
| 18 | ain93m | 1 |
| 19 | all-trans-form | 1 |
| 20 | allo-hla | 1 |
| 21 | allograft-demineralized | 1 |
| 22 | anti-body | 1 |
| 23 | anti-glrav-3 | 1 |
| 24 | antiarrhythmically | 1 |
| 25 | berson | 1 |
| 26 | beta-strand | 1 |
| 27 | bg-dependent | 2 |
| 28 | binary-response | 1 |
| 29 | bpa-dose | 1 |
| 30 | carbon-source | 1 |
| 31 | ccck/18 | 1 |
| 32 | cell-type | 25 |
| 33 | ciebp | 1 |
| 34 | clincially | 1 |
| 35 | coaxially | 7 |
| 36 | colgate® | 2 |
| 37 | conjugally | 1 |
| 38 | conmed | 2 |
| 39 | coreopsis | 1 |
| 40 | c₃₃₋₄₄ | 1 |
| 41 | diaspirin | 6 |
| 42 | donor-acceptor-type | 1 |
| 43 | donor-selected | 1 |
| 44 | double-stimuli | 1 |
| 45 | drug-layered | 1 |
| 46 | dznep-derived | 1 |
| 47 | electrocatalytically | 1 |
| 48 | electropolymeric | 1 |
| 49 | embolising | 1 |
| 50 | erythemally | 1 |
| 51 | evalutionary | 1 |
| 52 | exquisitely | 26 |
| 53 | fkb-5 | 1 |
| 54 | foran | 2 |
| 55 | glaserian | 1 |
| 56 | goal-conscious | 1 |
| 57 | gtx2,3-aldehyde- | 1 |
| 58 | guanidine-based | 1 |
| 59 | h19-differentially | 2 |
| 60 | h3.1-containing | 1 |
| 61 | health-sector | 2 |
| 62 | heparin-saturated | 1 |
| 63 | heterogeneously/extremely | 1 |
| 64 | hexadecameric | 1 |
| 65 | high-nociception | 1 |
| 66 | highly | 14,470 |
| 67 | highy | 1 |
| 68 | hippocampal-region | 1 |
| 69 | hiv-suppressing | 1 |
| 70 | hla-f. | 1 |
| 71 | hydrolytically | 5 |
| 72 | inconstantly | 2 |
| 73 | ion- | 1 |
| 74 | isosequential | 1 |
| 75 | jnk2/3 | 5 |
| 76 | literature-guided | 1 |
| 77 | locally-produced | 2 |
| 78 | lowly | 5 |
| 79 | m.d-08 | 1 |
| 80 | magnesium-incorporated | 3 |
| 81 | magnesium-non | 1 |
| 82 | meca79 | 1 |
| 83 | megalin- | 1 |
| 84 | microbe-encapsulated | 2 |
| 85 | model.if | 1 |
| 86 | ms/thermally | 1 |
| 87 | multiantibiotic | 1 |
| 88 | nanopatterned | 1 |
| 89 | nm-thick | 1 |
| 90 | non-centrally | 1 |
| 91 | non-cox-2 | 6 |
| 92 | non-dose | 1 |
| 93 | non-g6pd | 2 |
| 94 | non-gastro | 1 |
| 95 | non-radiating | 1 |
| 96 | non-renin | 1 |
| 97 | non-subunit | 1 |
| 98 | non-water | 2 |
| 99 | nonfluoxetine | 1 |
| 100 | nongravity | 1 |
| 101 | nonlight | 1 |
| 102 | nonspecifying | 1 |
| 103 | not-yet-annotated | 1 |
| 104 | novel-type | 1 |
| 105 | one-generation | 1 |
| 106 | othermore | 1 |
| 107 | ozone-transfer | 1 |
| 108 | paparella | 1 |
| 109 | partner-bond | 1 |
| 110 | peculiarly | 3 |
| 111 | perennially | 1 |
| 112 | perfluorocarbon-exposed | 1 |
| 113 | pet-ether | 1 |
| 114 | physicologist | 1 |
| 115 | phytoestrogen- | 1 |
| 116 | pigmentation-inducing | 1 |
| 117 | plant-bound | 1 |
| 118 | plcc | 1 |
| 119 | polybactrin | 1 |
| 120 | prelyophilized | 1 |
| 121 | presolidified | 2 |
| 122 | priviledged | 2 |
| 123 | promitor™ | 1 |
| 124 | protoglycan-like | 1 |
| 125 | random-priming | 1 |
| 126 | rapid-heat | 1 |
| 127 | relaparatomy | 1 |
| 128 | renouncing | 1 |
| 129 | retinotopically | 5 |
| 130 | rheumatoid-like | 1 |
| 131 | self-report-clinician | 1 |
| 132 | ser/pro | 1 |
| 133 | significant/ | 1 |
| 134 | single-place | 1 |
| 135 | sleep-state | 1 |
| 136 | smad2/3-dvl2/3 | 1 |
| 137 | subgame | 1 |
| 138 | submaximally | 4 |
| 139 | subtherapeutically | 1 |
| 140 | succinylnorcocaine | 1 |
| 141 | surpassingly | 1 |
| 142 | suxiao | 10 |
| 143 | target-parameter | 1 |
| 144 | temptative | 1 |
| 145 | tensilely | 1 |
| 146 | thoroughgoing | 1 |
| 147 | time-and | 3 |
| 148 | tlr4-pathway | 1 |
| 149 | tonally | 2 |
| 150 | triacylglycerol- | 1 |
| 151 | triaxially | 1 |
| 152 | tttd-based | 2 |
| 153 | va/g | 1 |
| 154 | vasomotorically | 1 |
| 155 | water-excluded | 1 |
| 156 | water-vapor | 1 |
| 157 | wider-caliber | 1 |
| 158 | worry/rumination | 1 |
| 159 | wrightia | 8 |
| 160 | x/y/18 | 1 |
| 161 | ~4,800 | 1 |
| 162 | α-1,3-linked | 1 |
| 163 | β-1,6-n-acetylglucosamine | 1 |
| 164 | π-functional | 1 |
| 165 | ≥52-week | 1 |
| 1 | gtx2,3-aldehyde- | 1 |
| 2 | triacylglycerol- | 1 |
| 3 | phytoestrogen- | 1 |
| 4 | megalin- | 1 |
| 5 | ion- | 1 |
| 6 | hla-f. | 1 |
| 7 | significant/ | 1 |
| 8 | ~4,800 | 1 |
| 9 | 249,040 | 1 |
| 10 | 23/681 | 1 |
| 11 | non-cox-2 | 6 |
| 12 | anti-glrav-3 | 1 |
| 13 | jnk2/3 | 5 |
| 14 | smad2/3-dvl2/3 | 1 |
| 15 | 17p-/tp53 | 1 |
| 16 | fkb-5 | 1 |
| 17 | 30,176 | 1 |
| 18 | m.d-08 | 1 |
| 19 | ccck/18 | 1 |
| 20 | x/y/18 | 1 |
| 21 | meca79 | 1 |
| 22 | 226-kda | 1 |
| 23 | wrightia | 8 |
| 24 | allo-hla | 1 |
| 25 | paparella | 1 |
| 26 | 3'-dh-cama/b | 1 |
| 27 | plcc | 1 |
| 28 | hexadecameric | 1 |
| 29 | electropolymeric | 1 |
| 30 | multiantibiotic | 1 |
| 31 | locally-produced | 2 |
| 32 | literature-guided | 1 |
| 33 | water-excluded | 1 |
| 34 | priviledged | 2 |
| 35 | presolidified | 2 |
| 36 | α-1,3-linked | 1 |
| 37 | conmed | 2 |
| 38 | nanopatterned | 1 |
| 39 | drug-layered | 1 |
| 40 | tttd-based | 2 |
| 41 | 4-substituted-1-tosyl-1,2,3-triazole-based | 1 |
| 42 | guanidine-based | 1 |
| 43 | 5-ht-based | 1 |
| 44 | perfluorocarbon-exposed | 1 |
| 45 | microbe-encapsulated | 2 |
| 46 | magnesium-incorporated | 3 |
| 47 | heparin-saturated | 1 |
| 48 | not-yet-annotated | 1 |
| 49 | donor-selected | 1 |
| 50 | dznep-derived | 1 |
| 51 | allograft-demineralized | 1 |
| 52 | prelyophilized | 1 |
| 53 | 'wind-cold | 1 |
| 54 | 158-fold | 1 |
| 55 | time-and | 3 |
| 56 | beta-strand | 1 |
| 57 | partner-bond | 1 |
| 58 | plant-bound | 1 |
| 59 | non-g6pd | 2 |
| 60 | single-place | 1 |
| 61 | carbon-source | 1 |
| 62 | rheumatoid-like | 1 |
| 63 | protoglycan-like | 1 |
| 64 | 3'utr/lectin-like | 1 |
| 65 | subgame | 1 |
| 66 | 3,5-dihydroxy-4-isopropystilbene | 1 |
| 67 | succinylnorcocaine | 1 |
| 68 | adenine-uridine | 1 |
| 69 | β-1,6-n-acetylglucosamine | 1 |
| 70 | nonfluoxetine | 1 |
| 71 | novel-type | 1 |
| 72 | cell-type | 25 |
| 73 | donor-acceptor-type | 1 |
| 74 | othermore | 1 |
| 75 | binary-response | 1 |
| 76 | bpa-dose | 1 |
| 77 | non-dose | 1 |
| 78 | sleep-state | 1 |
| 79 | temptative | 1 |
| 80 | 1-df | 1 |
| 81 | model.if | 1 |
| 82 | va/g | 1 |
| 83 | renouncing | 1 |
| 84 | pigmentation-inducing | 1 |
| 85 | random-priming | 1 |
| 86 | h3.1-containing | 1 |
| 87 | thoroughgoing | 1 |
| 88 | embolising | 1 |
| 89 | hiv-suppressing | 1 |
| 90 | non-radiating | 1 |
| 91 | nonspecifying | 1 |
| 92 | double-stimuli | 1 |
| 93 | nm-thick | 1 |
| 94 | ≥52-week | 1 |
| 95 | isosequential | 1 |
| 96 | π-functional | 1 |
| 97 | ain93m | 1 |
| 98 | all-trans-form | 1 |
| 99 | self-report-clinician | 1 |
| 100 | glaserian | 1 |
| 101 | foran | 2 |
| 102 | agent/regimen | 1 |
| 103 | non-renin | 1 |
| 104 | diaspirin | 6 |
| 105 | polybactrin | 1 |
| 106 | hippocampal-region | 1 |
| 107 | worry/rumination | 1 |
| 108 | one-generation | 1 |
| 109 | high-nociception | 1 |
| 110 | magnesium-non | 1 |
| 111 | berson | 1 |
| 112 | suxiao | 10 |
| 113 | ser/pro | 1 |
| 114 | non-gastro | 1 |
| 115 | ciebp | 1 |
| 116 | wider-caliber | 1 |
| 117 | ozone-transfer | 1 |
| 118 | pet-ether | 1 |
| 119 | non-water | 2 |
| 120 | target-parameter | 1 |
| 121 | water-vapor | 1 |
| 122 | health-sector | 2 |
| 123 | coreopsis | 1 |
| 124 | 13-ms | 1 |
| 125 | goal-conscious | 1 |
| 126 | rapid-heat | 1 |
| 127 | nonlight | 1 |
| 128 | non-subunit | 1 |
| 129 | bg-dependent | 2 |
| 130 | physicologist | 1 |
| 131 | tlr4-pathway | 1 |
| 132 | anti-body | 1 |
| 133 | highy | 1 |
| 134 | tensilely | 1 |
| 135 | heterogeneously/extremely | 1 |
| 136 | exquisitely | 26 |
| 137 | surpassingly | 1 |
| 138 | highly | 14,470 |
| 139 | antiarrhythmically | 1 |
| 140 | retinotopically | 5 |
| 141 | vasomotorically | 1 |
| 142 | subtherapeutically | 1 |
| 143 | electrocatalytically | 1 |
| 144 | hydrolytically | 5 |
| 145 | conjugally | 1 |
| 146 | clincially | 1 |
| 147 | perennially | 1 |
| 148 | h19-differentially | 2 |
| 149 | triaxially | 1 |
| 150 | coaxially | 7 |
| 151 | erythemally | 1 |
| 152 | submaximally | 4 |
| 153 | ms/thermally | 1 |
| 154 | tonally | 2 |
| 155 | non-centrally | 1 |
| 156 | peculiarly | 3 |
| 157 | inconstantly | 2 |
| 158 | lowly | 5 |
| 159 | relaparatomy | 1 |
| 160 | evalutionary | 1 |
| 161 | nongravity | 1 |
| 162 | c₃₃₋₄₄ | 1 |
| 163 | promitor™ | 1 |
| 164 | colgate® | 2 |
| 165 | 1°-32° | 1 |